Safety, Tolerability, Pharmacokinetics of Single Rising Oral Doses of BI 1181181 in Healthy Male Volunteers, Including Investigation of the Effect of Food on the Bioavailability of BI 1181181

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

January 31, 2014

Primary Completion Date

September 30, 2014

Study Completion Date

September 30, 2014

Conditions

Healthy

Interventions

DRUG

BI 1181181

single dose (low to high dose)

DRUG

BI 1181181, R

powder for oral solution

DRUG

BI 1181181, T2

tablet, fasted

DRUG

Placebo to BI 1181181

DRUG

BI 1181181, T1

tablet, fed

Trial Locations (1)

1344.1.1 Boehringer Ingelheim Investigational Site, Ingelheim